Our research focused on B-ALL cell lines expressing exogenous KRAS-G12D, additional models (e.g., knockin cell lines and transgenic mice) would be needed to make the conclusion more universally applicable. The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.